Haemonetics Corp. buy Needham & Company LLC
Start price
15.11.24
/
50%
€84.00
Target price
15.11.25
€106.41
Performance (%)
-25.60%
End price
16.11.25
€62.50
Summary
This prediction ended on 16.11.25 with a price of €62.50. The price of Haemonetics Corp. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -25.60%. Needham___Company_LL has a follow-up prediction for Haemonetics Corp. where he still thinks Haemonetics Corp. is a Buy. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Haemonetics Corp. | -7.746% | -7.746% | - |
| iShares Core DAX® | 0.191% | 4.892% | 22.046% |
| iShares Nasdaq 100 | -0.614% | 2.901% | 7.804% |
| iShares Nikkei 225® | 0.599% | 7.404% | 22.218% |
| iShares S&P 500 | -0.036% | 3.489% | 4.833% |
Comments by Needham___Company_LL for this prediction
In the thread Haemonetics Corp. diskutieren
Haemonetics Co. (NYSE: HAE) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $112.00 price target on the stock.
Ratings data for HAE provided by MarketBeat
In the thread Trading Haemonetics Corp.
Die von Needham___Company_LL gewählte maximale Laufzeit wurde überschritten
Current prediction by Needham___Company_LL for Haemonetics Corp.
Haemonetics Corp.
Start price
Target price
Perf. (%)
€57.00
07.02.25
07.02.25
€104.18
07.02.26
07.02.26
10.53%
14.01.26
14.01.26
Stopped prediction by Needham___Company_LL for Haemonetics Corp.
Haemonetics Corp.
Start price
Target price
Perf. (%)
€49.00
07.08.25
07.08.25
€58.31
07.08.26
07.08.26
28.57%
14.01.26
14.01.26
Haemonetics Corp.
Start price
Target price
Perf. (%)
€80.50
03.12.24
03.12.24
€106.36
03.12.25
03.12.25
-14.29%
04.12.25
04.12.25
Haemonetics Corp.
Start price
Target price
Perf. (%)
€79.00
12.06.24
12.06.24
€103.42
12.06.25
12.06.25
-24.68%
13.06.25
13.06.25